GO:0090083 regulation of inclusion body assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090083 (regulation of inclusion body assembly) is a biological process that modulates the rate, frequency, or extent of inclusion body assembly, the aggregation and bonding of components into an inclusion body.
• Inclusion bodies are micron-scale protein aggregates that form when misfolded or aggregation-prone proteins overwhelm the cellular proteostasis machinery, and their assembly is tightly regulated by chaperones, post-translational modifications, and phase-separation events.
• CRISPR-based genome-wide screens have identified specific regulators of inclusion formation, including SRRD, which links intermediate filament dynamics to aggresome assembly.
• Nuclear bodies such as nucleoli, P-bodies, and replication compartments are regulated inclusion-like assemblies whose scaffolding depends on architectural RNAs and specific proteins.
• Dysregulation of inclusion body assembly is mechanistically linked to neurodegeneration (TDP-43, alpha-synuclein), viral replication, and proteostasis-related diseases.
• Experimental dissection of GO:0090083 requires a combination of CRISPR knockout/knock-in models, live-cell imaging, proteomics, and transcriptomics to resolve cause versus consequence in inclusion biology.
Description
Inclusion bodies are intracellular aggregates that form when proteins or other macromolecules assemble into discrete, often micron-scale structures. The biological process that controls the rate, frequency, or extent of this assembly is formally annotated as GO:0090083, regulation of inclusion body assembly. This term captures a critical layer of cellular control: inclusion bodies do not simply appear when proteins misfold; their formation is actively modulated by chaperones, post-translational modifications, RNA scaffolds, and phase-separation events. Understanding this regulation is essential because inclusion bodies are central to both normal physiology, such as nuclear body function, and pathology, including neurodegeneration and viral replication. Recent advances in functional genomics have begun to map the regulators of inclusion body assembly. A genome-wide CRISPR screen for protein inclusion formation identified SRRD as a regulator of intermediate filament dynamics and aggresome assembly, demonstrating that inclusion formation is genetically tractable. Parallel work on nuclear bodies has revealed that architectural RNAs and specific proteins scaffold these structures, providing mechanistic parallels to cytoplasmic inclusion bodies. In addition, biophysical studies of alpha-synuclein have shown that early oligomers regulate self-assembly through nucleation and liquid-liquid phase separation, directly linking the regulation of inclusion body assembly to protein biophysics. For researchers, GO:0090083 provides a conceptual and experimental framework to ask how cells decide whether, when, and where to build an inclusion body. This article synthesizes the current understanding of the term, its molecular players, disease relevance, and the CRISPR-based methods used to study it.
regulation of inclusion body assembly At A Glance
| GO ID | GO:0090083 |
|---|---|
| GO term | regulation of inclusion body assembly |
| Ontology | biological_process |
| Synonym | None |
| Definition | Any process that modulates the rate, frequency, or extent of inclusion body assembly. Inclusion body assembly is the aggregation, arrangement and bonding together of a set of components to form an inclusion body. |
| Major function | Controls the formation, timing, and extent of inclusion bodies, including aggresomes, nuclear bodies, and stress-induced aggregates. |
| Related processes | Protein aggregation, phase separation, aggresome assembly, nuclear body assembly, stress response. |
| Key regulators | SRRD, chaperones, architectural RNAs, alpha-synuclein oligomers, TDP-43, P-body components. |
| Disease relevance | Neurodegeneration, viral replication, proteostasis disorders. |
What Is GO:0090083?
GO:0090083, regulation of inclusion body assembly, is defined as any process that modulates the rate, frequency, or extent of inclusion body assembly. Inclusion body assembly itself is the aggregation, arrangement, and bonding together of a set of components to form an inclusion body. In practice, this means the term covers molecular events that promote, inhibit, delay, or spatially direct the formation of inclusion bodies, including chaperone activity, post-translational modifications, phase separation, and scaffolding by RNAs or proteins.
Why Is regulation of inclusion body assembly Important in Cell Biology?
Regulation of inclusion body assembly is important because inclusion bodies are not passive deposits; they are actively controlled structures that influence cell survival, proteostasis, and disease progression. Dysregulated inclusion formation is a hallmark of neurodegenerative diseases such as amyotrophic lateral sclerosis and Parkinson's disease, where proteins like TDP-43 and alpha-synuclein aggregate. In viral infections, inclusion-like replication compartments are essential for efficient genome replication. Moreover, nuclear bodies regulated by similar principles organize the genome and modulate gene expression. Thus, understanding GO:0090083 provides mechanistic insight into both fundamental cell biology and multiple human diseases.
• Inclusion bodies are linked to neurodegeneration, including TDP-43 proteinopathies and alpha-synucleinopathies.
• Regulation of inclusion assembly affects viral replication, as shown for equine alphaherpesvirus 1 replication compartments.
• Nuclear bodies such as nucleoli and P-bodies are regulated inclusion-like assemblies that control RNA processing and genome organization.
• CRISPR screens have identified specific regulators like SRRD, making the process genetically dissectable.
• Phase separation and nucleation are key biophysical mechanisms that regulate inclusion formation.
• Inclusion body regulation is relevant to proteostasis, stress responses, and cellular aging.
• Understanding this process can guide therapeutic strategies to prevent or dissolve pathological aggregates.
• It provides a framework for studying how cells compartmentalize biochemical reactions under stress.
• Regulation of inclusion assembly is conserved across cell types and organisms, from yeast to humans.
• It connects to RNA biology, as architectural RNAs scaffold nuclear bodies and P-bodies.
What Happens During regulation of inclusion body assembly?
Initiation and Nucleation
In simple terms: The first step is when a few protein molecules start sticking together to form a tiny seed.
Inclusion body assembly begins with nucleation, where a small number of aggregation-prone proteins or oligomers come together to form a seed. Biophysical studies of alpha-synuclein have shown that early oligomers regulate self-assembly through nucleation and liquid-liquid phase separation, meaning that the initial clustering of molecules is a regulated event. This nucleation step is modulated by local concentration, post-translational modifications, and interactions with other proteins or RNAs.
Phase Separation and Condensate Formation
In simple terms: Proteins can separate into droplets like oil in water, forming a distinct phase where inclusion bodies start to take shape.
Liquid-liquid phase separation (LLPS) is a key mechanism that regulates inclusion body assembly. Alpha-synuclein early oligomers undergo LLPS, which can promote or inhibit further aggregation depending on conditions. Similarly, nuclear bodies scaffolded by architectural RNAs form through phase separation, and their assembly is regulated by RNA-protein interactions. This step determines whether a diffuse protein pool condenses into a distinct inclusion body.
Scaffolding by Proteins and RNAs
In simple terms: Certain molecules act like a skeleton, giving the inclusion body its shape and holding it together.
Inclusion bodies often require scaffolds to assemble properly. In nuclear bodies, architectural RNAs serve as scaffolds that recruit proteins and regulate assembly. In the nucleolus, a nucleolus-tethering system (NoTS) has been used to study how specific components regulate nucleolar assembly. For aggresomes, SRRD regulates intermediate filament dynamics, which in turn affects aggresome assembly. These scaffolds ensure that inclusion bodies form at the right place and time.
Maturation and Clearance
In simple terms: Once formed, inclusion bodies can grow, change, or be taken apart by the cell.
After nucleation and scaffolding, inclusion bodies mature into larger structures. This maturation is regulated by chaperones, proteases, and autophagy. For example, DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay, linking RNA processing to inclusion regulation. In viral infections, replication compartments are dynamic inclusion-like structures that mature and disassemble during the viral cycle. The balance between assembly and clearance determines the steady-state level of inclusion bodies.
Stress-Responsive Regulation
In simple terms: When cells are stressed, they can quickly change how inclusion bodies form.
Cellular stress strongly influences inclusion body assembly. Imaging stress responses has revealed that stress granules and related inclusions form rapidly upon stress and are regulated by signaling pathways. Stress-induced inclusion bodies can sequester misfolded proteins to protect cells, but chronic stress can lead to pathological aggregates. Thus, regulation of inclusion body assembly is integrated with the broader stress response network.
Key Genes Involved in GO:0090083 regulation of inclusion body assembly
The following genes and proteins have been experimentally implicated in the regulation of inclusion body assembly, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SRRD | Regulates intermediate filament dynamics and aggresome assembly | Identified in a CRISPR screen for protein inclusion formation |
| TDP-43 | RNA-binding protein that forms pathological inclusions | Linked to neurodegeneration; modulated by DCPS and P-bodies |
| SNCA (alpha-synuclein) | Early oligomers regulate self-assembly via nucleation and LLPS | Parkinson's disease model for inclusion regulation |
| DCPS | Modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay | Potential therapeutic target for TDP-43 proteinopathies |
| Nucleolin | Major nucleolar protein; studied via NoTS | Nucleolus assembly and regulation |
| Fibrillarin | Nucleolar protein; component of architectural RNA-scaffolded bodies | Nuclear body assembly |
| EHV1 proteins | Form replication compartments (inclusion-like) | Viral inclusion regulation |
| Histones | Mobilized within EHV1 replication compartments | Chromatin regulation in viral inclusions |
| P-body components | Regulate RNA decay and inclusion dynamics | Linked to TDP-43 pathology |
| Chaperones (HSP70/HSP40) | Assist protein folding and prevent aggregation | General regulators of inclusion assembly |
| Autophagy receptors | Clear inclusion bodies | Regulate inclusion turnover |
| Architectural RNAs | Scaffold nuclear bodies | Regulate assembly of nuclear inclusions |
| Intermediate filaments | Cytoskeletal components affecting aggresome formation | Regulated by SRRD |
| Proteasome subunits | Degrade misfolded proteins | Influence inclusion formation |
| Stress granule proteins | Form stress-induced inclusions | Imaging stress responses |
| Nuclear body proteins | Organize genome spatially | Emerging roles in genome organization |
How Is regulation of inclusion body assembly Regulated?
Regulation of inclusion body assembly is controlled at multiple levels. Post-translational modifications such as phosphorylation can alter the aggregation propensity of proteins like TDP-43 and alpha-synuclein. Chaperones and co-chaperones modulate folding and prevent or promote aggregation. RNA scaffolds, including architectural RNAs, direct the assembly of nuclear bodies. In viral infections, viral proteins and host factors regulate the formation of replication compartments. Additionally, signaling pathways such as the integrated stress response can influence inclusion dynamics. The interplay between these regulators determines whether inclusion bodies form, persist, or are cleared.
regulation of inclusion body assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TDP-43 | Amyotrophic lateral sclerosis, frontotemporal dementia | Knockout or point-mutation iPSC-derived neurons |
| SNCA | Parkinson's disease | Knock-in of A53T mutation in SH-SY5Y cells |
| SRRD | Aggresome regulation; potential cancer relevance | CRISPR knockout in HeLa cells |
| DCPS | TDP-43-linked neurodegeneration | Overexpression and knockout in neuronal cell lines |
| EHV1 proteins | Viral replication compartments | Infection of equine cells with tagged viral proteins |
Neurodegeneration
Dysregulation of inclusion body assembly is a central feature of neurodegenerative diseases. TDP-43 inclusions are hallmarks of amyotrophic lateral sclerosis and frontotemporal dementia, and DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay. Alpha-synuclein early oligomers regulate self-assembly through nucleation and LLPS, and their dysregulation leads to Lewy body formation in Parkinson's disease. Thus, targeting the regulation of inclusion body assembly may offer therapeutic strategies.
Viral Replication
Many viruses form inclusion-like replication compartments that are essential for their life cycle. Equine alphaherpesvirus 1 (EHV1) mobilizes histones within its replication compartments, which are regulated inclusion-like structures. Understanding how these compartments assemble could lead to antiviral strategies that disrupt viral inclusion formation.
Nuclear Body Dysfunction and Genome Organization
Nuclear bodies such as nucleoli, P-bodies, and others are regulated inclusion-like assemblies that organize the genome and control gene expression. Disruption of their assembly can lead to genome instability and disease. Architectural RNAs scaffold these bodies, and their regulation is critical for normal cellular function.
From regulation of inclusion body assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate inclusion body assembly? | CRISPR knockout cell line followed by imaging |
| Does a specific mutation alter inclusion formation? | Point-mutation knock-in cell line |
| Where does protein X localize during inclusion assembly? | Tagged knock-in with fluorescent protein |
| Does overexpression of gene Y induce inclusions? | Doxycycline-inducible overexpression cell line |
| Which genes regulate inclusion formation genome-wide? | CRISPR library screening |
| What is the transcriptomic signature of inclusion-bearing cells? | RNA-seq of sorted cells |
How to Study the regulation of inclusion body assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene requirement for inclusion formation | Identify novel regulators like SRRD |
| Live-cell fluorescence imaging | Dynamics and localization of inclusions | Track assembly/disassembly in real time |
| Proteomics | Protein composition of inclusions | Identify co-aggregating proteins |
| RNA-seq | Transcriptional changes | Compare inclusion-bearing vs control cells |
| FRAP/FLIP | Molecular mobility within inclusions | Assess liquid vs solid nature |
| Co-immunoprecipitation | Protein-protein interactions | Map inclusion assembly complexes |
| Single-molecule imaging | Oligomerization states | Study nucleation of alpha-synuclein |
| CRISPR knock-in tagging | Endogenous protein localization | Visualize native inclusion proteins |
CRISPR Screens for Inclusion Regulators
Genome-wide CRISPR screens are powerful for identifying regulators of inclusion body assembly. A recent screen for protein inclusion formation uncovered SRRD as a regulator of intermediate filament dynamics and aggresome assembly. This approach allows unbiased discovery of genes that promote or inhibit inclusion formation.
Live-Cell Imaging of Inclusion Dynamics
Live-cell imaging with fluorescently tagged proteins enables real-time visualization of inclusion body assembly and disassembly. Imaging stress responses has revealed rapid formation of stress-induced inclusions. This method is essential for understanding the kinetics and regulation of inclusion assembly.
Proteomics and Interactomics
Mass spectrometry-based proteomics can identify proteins that co-aggregate with inclusion bodies or interact with regulators. For example, proteomic analysis of viral replication compartments has revealed histone mobilization. This helps define the composition and regulation of inclusion bodies.
Transcriptomics and RNA Biology
RNA-seq and related techniques can reveal transcriptional changes associated with inclusion formation. P-body-mediated RNA decay regulated by DCPS modulates TDP-43-linked neurodegeneration, highlighting the role of RNA processing. Architectural RNAs scaffold nuclear bodies, and their study requires RNA-centric methods.
How CRISPR Can Be Used to Study GO:0090083 regulation of inclusion body assembly
Knockout
CRISPR knockout is used to delete candidate regulators of inclusion body assembly and assess the effect on inclusion formation. For example, knockout of SRRD alters aggresome assembly. This approach establishes causality.
Point Mutation
Point mutations can be introduced to model disease-associated variants, such as TDP-43 mutations, and study their impact on inclusion assembly. This helps dissect the contribution of specific residues to regulation.
Knock-in
Knock-in of fluorescent tags or disease mutations allows visualization and functional analysis of endogenous proteins during inclusion assembly. Tagged knock-in of alpha-synuclein can reveal its role in nucleation.
Overexpression
Overexpression of aggregation-prone proteins or their regulators can induce or suppress inclusion formation. Inducible overexpression systems are useful to study the dose-dependent effects on inclusion body assembly.
How EDITGENE Supports regulation of inclusion body assembly Research
Researchers studying regulation of inclusion body assembly-related genes often need to determine whether a candidate gene is causally involved in inclusion formation, how specific mutations affect assembly, and where the protein localizes. EDITGENE provides a comprehensive suite of CRISPR services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of inclusion body assembly research.
Frequently Asked Questions About regulation of inclusion body assembly
What is GO:0090083 regulation of inclusion body assembly?
GO:0090083 is a Gene Ontology biological process term defined as any process that modulates the rate, frequency, or extent of inclusion body assembly, where inclusion body assembly is the aggregation, arrangement, and bonding of components to form an inclusion body.
What genes are involved in regulation of inclusion body assembly?
Key genes include SRRD, TDP-43, SNCA (alpha-synuclein), DCPS, and components of nuclear bodies and P-bodies, as identified in CRISPR screens and other studies.
How do CRISPR screens help study inclusion body assembly?
CRISPR screens allow unbiased identification of genes that regulate inclusion formation. For example, a genome-wide screen identified SRRD as a regulator of aggresome assembly.
What diseases are linked to inclusion body assembly?
Neurodegenerative diseases such as ALS and Parkinson's disease, as well as viral infections, are linked to dysregulated inclusion body assembly.
What is the role of phase separation in inclusion body assembly?
Liquid-liquid phase separation (LLPS) regulates the formation of inclusion bodies by concentrating proteins into droplets, as shown for alpha-synuclein.
How can I study regulation of inclusion body assembly in my lab?
You can use CRISPR knockout, knock-in, overexpression models, live-cell imaging, proteomics, and transcriptomics. EDITGENE provides these services.
What are nuclear bodies and how do they relate to inclusion bodies?
Nuclear bodies are membrane-less compartments that assemble via similar principles to inclusion bodies, often scaffolded by architectural RNAs.
What is the role of SRRD in inclusion body assembly?
SRRD regulates intermediate filament dynamics and aggresome assembly, as identified in a CRISPR screen.
How does TDP-43 contribute to inclusion formation?
TDP-43 forms pathological inclusions in neurodegeneration, and its regulation involves P-body-mediated RNA decay modulated by DCPS.
Can inclusion body assembly be targeted therapeutically?
Yes, understanding its regulation may lead to therapies that prevent or clear pathological inclusions, though more research is needed.
Conclusion
GO:0090083 regulation of inclusion body assembly is a fundamental biological process that controls the formation of diverse intracellular aggregates, from aggresomes to nuclear bodies. Its dysregulation is implicated in neurodegeneration, viral replication, and genome organization. Recent CRISPR screens and biophysical studies have begun to uncover the molecular players, including SRRD, TDP-43, and alpha-synuclein. Continued research using advanced CRISPR models and imaging will further illuminate how cells regulate inclusion assembly and how this can be harnessed for therapeutic benefit.
References
- 1. Sweeney KM et al.. 2024. CRISPR screen for protein inclusion formation uncovers a role for SRRD in the regulation of intermediate filament dynamics and aggresome assembly.. PLoS Genet 20(2):e1011138 PMID: 38315730
- 2. Brielle S et al.. 2015. Imaging stress.. Cell Stress Chaperones 20(6):867-74 PMID: 26139131
- 3. Liu Y et al.. 2014. Nucleolus-tethering system (NoTS).. Nucleus 5(4):293-7 PMID: 25482117
- 4. Yamamoto T et al.. 2025. Biophysical Aspect of Assembly and Regulation of Nuclear Bodies Scaffolded by Architectural RNA.. J Mol Biol 437(9):169016 PMID: 39978724
- 5. Shan L et al.. 2024. Emerging roles of nuclear bodies in genome spatial organization.. Trends Cell Biol 34(7):595-605 PMID: 37993310
- 6. Ye Y et al.. 2026. DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay.. Neuron 114(11):1970-1985.e12 PMID: 41943580
- 7. Conn KL. 2025. Equine histones are mobilized within equid alphaherpesvirus 1 (EHV1) replication compartments.. J Virol 99(12):e0158925 PMID: 41288450
- 8. Wei M et al.. 2025. α-Synuclein Early-Oligomers Regulate Self-Assembly through Nucleation and Liquid-Liquid Phase Separation.. Biomacromolecules 26(11):8136-8145 PMID: 41147343
